Quick Takeaways
- Deborah Knobelman has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $572,470.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Deborah Knobelman
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Deborah Knobelman is at least $572,470 dollars as of 20 Jun 2025. Deborah Knobelman is the Chief Financial Officer, Head of Corporate Development of Senti Biosciences, Inc. and owns shares of Senti Biosciences, Inc. (SNTI) stock worth about $572.5K.
- Signature
- /s/ Deborah Knobelman
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Deborah Knobelman and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Senti Biosciences, Inc. ($572,470).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Deborah Knobelman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SNTI | Senti Biosciences, Inc. | Chief Financial Officer, Head of Corporate Development | $572,470 | 01 Feb 2024 | ||
| KRON | Kronos Bio, Inc. | President & Interim CEO | $0 | -$21,554 | -100% | 20 Jun 2025 |
Insider Transactions Reported by Deborah Knobelman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.